Constellation Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Constellation Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-43,382	Closed	-$5.08M	–	115
2015 Q2	$5.08M	Sell	43,382 -4,855	-10%	-$531K	0.43%	54
2015 Q1	$4.73M	Buy	48,237 +3,349	+7%	+$340K	0.42%	60
2014 Q4	$4.23M	Hold	44,888	–	–	0.35%	56
2014 Q3	$4.78M	Sell	44,888 -6,222	-12%	-$609K	0.44%	48
2014 Q2	$4.24M	Sell	51,110 -5,178	-9%	-$403K	0.48%	53
2014 Q1	$3.99M	Sell	56,288 -3,440	-6%	-$270K	0.39%	70
2013 Q4	$4.49M	Buy	59,728 +1,678	+3%	+$117K	0.43%	60
2013 Q3	$3.65M	Buy	58,050 +10,924	+23%	+$653K	0.42%	60
2013 Q2	$2.42M	Buy	+47,126	New	+$2.46M	0.29%	76

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Constellation Wealth Advisors's GILD Position: Q3 2015 in Review

Constellation Wealth Advisors sold out of Gilead Sciences (GILD) in Q3 2015, closing a stake of 43,382 shares — an estimated $5.08M sold.

Constellation Wealth Advisors first reported a position in GILD in Q2 2013 and held it in 9 quarters. The position peaked at $5.08M in Q2 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

Constellation Wealth Advisors reported no remaining Gilead Sciences position as of Q3 2015 after selling out during the quarter.
Constellation Wealth Advisors sold 43,382 Gilead Sciences shares in Q3 2015, an estimated $5.08M.
Constellation Wealth Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 9 quarters.
Constellation Wealth Advisors's Gilead Sciences position peaked at $5.08M in Q2 2015.
1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Constellation Wealth Advisors's 13F filing for Q3 2015, filed 9 Nov 2015.